GlassScriptPhysician profile
Michael L Mlecko
NPI 1487644720
$25,520.80
in general payments reported to CMS, 2019-2025
21 companies · $4,103 in 2025
The $4,103 reported for 2025 was more than what 89% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $797 · 2020: $813 · 2022: $91.26 · 2024: $20K · 2025: $4,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $1,222 · Travel and Lodging: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,360.00 |
| Food and Beverage | $1,222.39 |
| Travel and Lodging | $237.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $23,804.07 | 2024-2025 | Voquezna |
| Abbvie INC. | $355.79 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $209.36 | 2019-2020 | |
| Allergan, INC. | $158.12 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $151.58 | 2019 | |
| Pfizer INC. | $151.12 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $134.12 | 2019-2020 | |
| Janssen Biotech, INC. | $133.53 | 2020 | |
| Medtronic, INC. | $91.26 | 2022 | |
| Ucb, INC. | $65.02 | 2019-2020 | |
| Vivus LLC | $36.77 | 2020 | |
| Ethicon US, LLC | $35.17 | 2020 | |
| Intercept Pharmaceuticals, INC. | $34.54 | 2019-2020 | |
| Concordia Pharmaceuticals INC. | $27.43 | 2019 | |
| Shionogi INC | $24.74 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $24.09 | 2019-2020 | |
| Qol Medical, LLC | $21.07 | 2020 | |
| Redhill Biopharma INC. | $18.04 | 2020 | |
| Shire North American Group INC | $17.69 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.31 | 2019 | |
| Alfasigma USA, INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mlecko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.